US FDA Commissioner Search: Did Sharpless’ Hopes Just Go Up In Smoke?
US FDA Acting Commissioner Sharpless’ time in office may be rapidly running out. The Trump Administration appears ready to pick an outside candidate to run FDA, with MD Anderson’s Hahn now the apparent front-runner. A prominent Democratic Senator’s criticism of Sharpless and his response to vaping may be the final blow.
You may also be interested in...
Media reports say President Trump will nominate Stephen Hahn, an oncologist serving as chief medical executive of MD Anderson Cancer Center, as the next US FDA commissioner. This comes despite a group of former agency chiefs’ support for the current acting commissioner, Ned Sharpless, to permanently fill the spot.
Ned Sharpless has been acting head of the US FDA for five months but has not yet been formally nominated for the permanent post. The emergence of another new name as a possible candidate underscores how uncertain the transition still is.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.